Achaogen, Inc.
Quick facts
Phase 3 pipeline
- antibiotic of Investigator's choice · Infectious Disease
This antibiotic inhibits bacterial protein synthesis by binding to the bacterial ribosome.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: